Immunotherapy in Hepatocellular Carcinoma

Clinical Care Options (CCO) on-demand video featuring global expert perspectives on using immuno-oncology therapies for urothelial cancer

Thomas Powles, MBBS, MRCP, MD Alain Ravaud, MD, PhD Released: October 15, 2020

Current Treatment Landscape in First-line Urothelial Cancer

Current Treatment Landscape for Second and Subsequent Lines of Therapy in Metastatic Urothelial Carcinoma

Ongoing Research and New Horizons for Urothelial Cancer

Download this slideset from Clinical Care Options, to see the latest data on first-line immunotherapy treatment options for patients with advanced HCC.

Ghassan K. Abou-Alfa, MD, MBA Released: October 14, 2020

Download this slideset from Clinical Care Options, to see the latest data on immunotherapy treatment options for patients with early HCC.

Peter R. Galle, MD, PhD Released: October 14, 2020

Downloadable slideset on best practices for biomarker testing in the treatment of patients with advanced NSCLC, from Clinical Care Options (CCO)

Lauren L. Ritterhouse, MD Released: October 13, 2020